Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy

T cell response. We show in an orthotopic pancreatic cancer model in male mice that the hydrogel microsphere vaccine transforms the immunologically cold tumour microenvironment into hot in a safe and efficient manner, thus significantly increasing survival and inhibiting the growth of distant metastases.